The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Raben David

Reporting owner CIK 0002034679 · Chief Medical Officer

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Raben DavidRaben DavidRaben David · October 1, 2026 · Stock award · Stock Option (Right to Buy)Raben David · December 26, 2025 · Exercise / conversion · Common StockRaben David · November 25, 2025 · Exercise / conversion · Common StockRaben David · November 25, 2025 · Exercise / conversion · Common StockRaben David · November 24, 2025 · Exercise / conversion · Common StockNov 24, 2025Oct 1, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 1, 2026PLIANT THERAPEUTICS, INC.Stock Option (Right to Buy)Raben DavidStock award
Dec 26, 2025Bicara Therapeutics Inc.Common StockRaben DavidExercise / conversion
Nov 25, 2025Bicara Therapeutics Inc.Common StockRaben DavidExercise / conversion
Nov 25, 2025Bicara Therapeutics Inc.Common StockRaben DavidExercise / conversion
Nov 24, 2025Bicara Therapeutics Inc.Common StockRaben DavidExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: PLIANT THERAPEUTICS, INC.PLRX · company listings
Raben DavidChief Medical Officer
Stock awardStock Option (Right to Buy)Derivative security · Code A575,0000Value: 0Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Raben DavidChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M19,7893.7898Value: 74,996.3522Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Raben DavidChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M9063.7898Value: 3,433.5588Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Raben DavidChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M4,5943.7898Value: 17,410.3412Currency not specifiedView ↗
Trade: Bicara Therapeutics Inc.BCAX · company listings
Raben DavidChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M5,5003.7898Value: 20,843.9Currency not specifiedView ↗